NCT03940066View on ClinicalTrials.gov

Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile

NACompletedINTERVENTIONAL

Enrollment

169

Participants

Timeline

Start Date

November 12, 2019

Primary Completion Date

April 8, 2024

Study Completion Date

June 1, 2024

Conditions

Atrial FibrillationSyncopeTachycardiaArrhythmias, CardiacHeart Diseases

Interventions

DEVICE

Biomonitor-2 and Kardia mobile

Implantable cardiac monitor and Smart-phone based electrocardiogram recording

OTHER

No Intervention

No intervention

Trial Locations (1)

39008

Hospital Universitario Marques de Valdecilla, Santander

All Listed Sponsors

lead

Fundación EPIC

OTHER

NCT03940066 - Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile | Biotech Hunter | Biotech Hunter